The Effectiveness and Safety of the Coronary Artery Serrated Cutting Balloon Dilation Catheter in the Pre-dilation of Coronary Artery Stenosis Lesions
Not Applicable
Not yet recruiting
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2025-04-13
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- JW Medical Systems Ltd
- Target Recruit Count
- 182
- Registration Number
- NCT06926400
Treatment of Primary Coronary Artery Vascular Lesions With Biolimus Coated Coronary Balloon Dilation Catheter
Not yet recruiting
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Biolimus Coated Coronary Artery Balloon Dilation Catheter
- First Posted Date
- 2024-04-25
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- JW Medical Systems Ltd
- Target Recruit Count
- 400
- Registration Number
- NCT06385067
Effectiveness and Safety of Coronary Scoring Balloon Dilation Catheter in the Pretreatment of Coronary Stenosis Lesions
Not Applicable
Not yet recruiting
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Coronary artery scoring balloon dilation catheter（JW Medical Systems Ltd）Device: ScoreFlex NC Coronary Dilatation Catheter
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- JW Medical Systems Ltd
- Target Recruit Count
- 200
- Registration Number
- NCT06291545
The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis
Not Applicable
Active, not recruiting
- Conditions
- Coronary Artery Disease
- Interventions
- Device: BiolimusDevice: SeQuent® Please Neo
- First Posted Date
- 2021-02-02
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- JW Medical Systems Ltd
- Target Recruit Count
- 310
- Registration Number
- NCT04733443
- Locations
- 🇨🇳
The First Medical Center of the PLA General Hospital, Beijing, Beijing, China
A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: BiolimusDevice: Powerline
- First Posted Date
- 2018-12-07
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- JW Medical Systems Ltd
- Target Recruit Count
- 206
- Registration Number
- NCT03769623
- Locations
- 🇨🇳
General Hospital of Northern Theater Command, Shenyang, Liaoning, China
A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT
Not Applicable
Not yet recruiting
- Conditions
- Coronary Artery Disease
- Interventions
- Device: EXCROSSAL
- First Posted Date
- 2018-10-23
- Last Posted Date
- 2018-10-23
- Lead Sponsor
- JW Medical Systems Ltd
- Target Recruit Count
- 2700
- Registration Number
- NCT03716011
- Locations
- 🇨🇳
JW Medical System, Beijing, Beijing, China
EXCEL-II Stent Vesus EXCEL Stent to Treat the Patients With de Novo Coronary Artery Lesions.
Completed
- Conditions
- Arterial Occlusive DiseasesCoronary Artery DiseaseHeart DiseasesCardiovascular DiseasesVascular DiseasesMyocardial IschemiaCoronary DiseaseArteriosclerosis
- Interventions
- Procedure: EXCEL-II DES implantationProcedure: EXCEL DES implatation
- First Posted Date
- 2014-02-07
- Last Posted Date
- 2023-04-26
- Lead Sponsor
- JW Medical Systems Ltd
- Target Recruit Count
- 419
- Registration Number
- NCT02057978
- Locations
- 🇨🇳
Shenyang Northern Hospital, Shenyang, Liaoning, China
EXCEL-II DES to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-III)
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: EXCEL-II biodegradable polymer sirolimus-eluting stent
- First Posted Date
- 2014-01-06
- Last Posted Date
- 2023-04-26
- Lead Sponsor
- JW Medical Systems Ltd
- Target Recruit Count
- 625
- Registration Number
- NCT02027870
- Locations
- 🇨🇳
Shenyang Northern Hospital, Shenyang, Liaoning, China
A Pilot First In Man Study of EXCEL-â…¡to Treat the Patients With de Novo Coronary Artery Lesions
Not Applicable
Completed
- Conditions
- Coronary Artery DiseaseIschemia
- Interventions
- Device: EXCEL-â…¡
- First Posted Date
- 2013-07-29
- Last Posted Date
- 2023-04-26
- Lead Sponsor
- JW Medical Systems Ltd
- Target Recruit Count
- 45
- Registration Number
- NCT01909869
- Locations
- 🇨🇳
Shenyang Northern Hospital, Shenyang, Liaoning, China
A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions
Phase 4
- Conditions
- IschemiaCardiac DeathMyocardial Infarction
- Interventions
- Device: Percutaneous Transluminal Coronary Angioplasty
- First Posted Date
- 2009-01-21
- Last Posted Date
- 2009-01-26
- Lead Sponsor
- JW Medical Systems Ltd
- Target Recruit Count
- 1944
- Registration Number
- NCT00825773
- Locations
- 🇨🇳
JW Medical Systems, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath